NMRA Neumora Therapeutics, Inc.

Fundamentals / CIK 0001885522 / USD

Neumora Therapeutics, Inc. reported $95.05M in total assets and a net loss of $190.4M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NMRA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$0$0$0-$227.9MFY 2022 Net Income: -$130.9M2022FY 2023 Net Income: -$235.9M2023FY 2024 Net Income: -$243.8M2024FY 2025 Net Income: -$236.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $176.1M $200.9M $142.7M $91.75M
Total Operating Expenses $241.2M $263.5M $252.1M $135.9M
Operating Income -$241.2M -$263.5M -$252.1M -$135.9M
EBITDA -$240.9M -$262.8M -$251.4M -$135.3M
Interest Income $8.34M $19.93M -- --
Interest Expense $2.01M $0 -- --
Income Before Tax -$236.8M -$243.6M -$235.7M -$130.9M
Income Tax Expense $130K $178K $268K --
Net Income -$236.9M -$243.8M -$235.9M -$130.9M
Basic EPS -$1.45 -$1.53 -$3.63 -$4.81
Diluted EPS -$1.45 -$1.53 -$3.63 -$4.81
Basic Shares Outstanding 163.4M 159.4M 65.0M 27.2M
Diluted Shares Outstanding 163.4M 159.4M 65.0M 27.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $22.61M $29.28M $38.60M $44.67M $40.52M $38.72M $52.15M $45.91M
Total Operating Expenses $33.41M $42.19M $52.86M $58.48M $57.70M $54.04M $70.94M $62.92M
Operating Income -$33.41M -$42.19M -$52.86M -$58.48M -$57.70M -$54.04M -$70.94M -$62.92M
EBITDA -$33.41M -$42.18M -$52.86M -$58.47M -$57.68M -$54.02M -$70.78M -$62.77M
Interest Income $809K $935K $1.23M $1.33M $1.69M $2.25M $3.07M --
Interest Expense $1.44M $1.43M $1.44M $2.04M $534K $307K $0 --
Income Before Tax -$34.44M -$43.08M -$53.43M -$59.45M -$56.76M -$52.71M -$67.89M -$58.82M
Income Tax Expense $0 $0 $30K $0 $0 $25K $105K --
Net Income -$34.44M -$43.08M -$53.46M -$59.45M -$56.76M -$52.73M -$67.99M -$58.82M
Basic EPS -$0.18 -$0.23 -$0.30 -- -$0.35 -$0.33 -$0.42 --
Diluted EPS -$0.18 -$0.23 -$0.30 -- -$0.35 -$0.33 -$0.42 --
Basic Shares Outstanding 187.9M 185.2M 179.9M -- 161.8M 161.7M 161.5M --
Diluted Shares Outstanding 187.9M 185.2M 179.9M -- 161.8M 161.7M 161.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $182.5M $142.1M $374.0M $240.9M
Short-Term Investments -- $165.4M $79.94M $130.9M
Cash & Short-Term Investments $182.5M $307.6M $454.0M $371.9M
Total Current Assets $190.5M $314.1M $478.3M $388.0M
Property, Plant & Equipment, Net $40K $1.14M $1.79M $2.41M
Long-Term Investments -- -- $9.85M $23.51M
Other Non-Current Assets $93K $0 -- $2.91M
Total Non-Current Assets $510K $2.92M $17.92M $38.28M
Total Assets $191.0M $317.0M $496.2M $426.2M
Accounts Payable $3.38M $3.31M $337K $7.15M
Short-Term Debt $60.00M -- -- --
Total Current Liabilities $32.45M $29.89M $25.11M $23.70M
Long-Term Debt $54.53M $0 -- --
Total Non-Current Liabilities $54.73M $22K $2.01M $5.70M
Total Liabilities $87.18M $29.91M $27.12M $29.40M
Total Debt (incl. Leases) $115.0M $1.85M $5.23M $8.44M
Common Stock $17K $16K $16K $3.0K
Retained Earnings -$1.18B -$947.2M -$703.4M -$467.5M
Accumulated Other Comp. Income -- $62K -$76K -$774K
Total Stockholders' Equity $103.9M $287.1M $469.1M -$446.9M
Total Equity $103.9M $287.1M $469.1M -$446.9M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $85.65M $116.8M $147.1M $182.5M $129.1M $124.5M $126.9M $142.1M
Short-Term Investments -- -- -- -- $42.45M $93.06M $122.5M $165.4M
Cash & Short-Term Investments $85.65M $116.8M $147.1M $182.5M $171.5M $217.6M $249.4M $307.6M
Total Current Assets $94.75M $124.9M $153.4M $190.5M $177.1M $222.9M $254.9M $314.1M
Property, Plant & Equipment, Net -- $25K $32K $40K $80K $87K $982K $1.14M
Other Non-Current Assets $66K $53K $53K $93K $197K $298K -- $0
Total Non-Current Assets $300K $375K $443K $510K $751K $916K $1.88M $2.92M
Total Assets $95.05M $125.2M $153.9M $191.0M $177.8M $223.8M $256.7M $317.0M
Accounts Payable $1.95M $4.15M $5.06M $3.38M $549K $644K $1.05M $3.31M
Short-Term Debt $60.00M $60.00M $60.00M $60.00M $20.00M $20.00M -- --
Total Current Liabilities $23.19M $27.78M $30.11M $32.45M $25.84M $21.16M $28.38M $29.89M
Long-Term Debt $53.30M $52.91M $52.96M $54.53M $19.56M $19.45M -- $0
Total Non-Current Liabilities $53.30M $52.95M $53.08M $54.73M $19.83M $19.79M $0 $22K
Total Liabilities $76.50M $80.73M $83.20M $87.18M $45.67M $40.95M $28.38M $29.91M
Total Debt (incl. Leases) $113.6M $113.3M $113.4M $115.0M $40.09M $39.96M $938K $1.85M
Common Stock $19K $19K $18K $17K $16K $16K $16K $16K
Retained Earnings -$1.32B -$1.28B -$1.24B -$1.18B -$1.12B -$1.07B -$1.02B -$947.2M
Accumulated Other Comp. Income -- -- -- -- $9.0K -$15K -$3.0K $62K
Total Stockholders' Equity $18.55M $44.52M $70.68M $103.9M $132.2M $182.9M $228.4M $287.1M
Total Equity $18.55M $44.52M $70.68M $103.9M $132.2M $182.9M $228.4M $287.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$236.9M -$243.8M -$235.9M -$130.9M
Depreciation & Amortization $208K $631K $668K $594K
Stock-Based Compensation $29.88M $39.99M $17.24M $8.30M
Change in Payables $71K $2.87M -$581K -$1.25M
Operating Cash Flow -$206.4M -$182.9M -$163.3M -$114.9M
Capital Expenditure -- -- -$117K -$511K
Free Cash Flow -- -- -$163.4M -$115.4M
Purchases of Investments -$82.87M -$312.2M -$109.1M -$226.4M
Investing Cash Flow $168.5M -$70.56M $64.39M -$168.0M
Common Stock Issued -- -- $810K --
Financing Cash Flow $77.09M $21.60M $231.9M $115.7M
Net Change in Cash $39.17M -$231.9M $133.0M -$167.2M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$34.44M -$43.08M -$53.46M -$59.45M -$56.76M -$52.73M -$67.99M -$58.82M
Depreciation & Amortization $3.0K $7.0K $8.0K $9.0K $23K $19K $157K $157K
Stock-Based Compensation $6.14M $7.18M $7.41M $7.41M $5.98M $7.17M $9.32M $9.90M
Change in Payables -$2.19M -$909K $1.68M $2.83M -$96K -$408K -$2.25M -$2.90M
Operating Cash Flow -$33.44M -$39.53M -$46.40M -$47.95M -$46.63M -$52.40M -$59.45M -$50.34M
Purchases of Investments $0 $0 $0 $0 $0 -$38.48M -$44.38M -$106.9M
Investing Cash Flow -$71K $0 $71K $42.65M $51.32M $30.40M $44.16M -$98.80M
Financing Cash Flow $2.33M $9.29M $10.88M $58.77M -$136K $18.46M $0 $15.57M
Net Change in Cash -$31.18M -$30.24M -$35.46M $53.46M $4.55M -$3.55M -$15.29M -$133.6M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -228.1% -84.9% -50.3% --
Return on Assets (ROA) -124.0% -76.9% -47.5% -30.7%
Current Ratio 5.87x 10.51x 19.05x 16.37x
Quick Ratio 5.62x 10.29x 18.08x 15.69x
Debt to Equity 1.11x 0.01x 0.01x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -1026.5% -477.9% -314.6% -228.1% -178.8% -137.8% -113.0% -84.9%
Return on Assets (ROA) -200.4% -169.9% -144.5% -124.0% -132.9% -112.6% -100.5% -76.9%
Current Ratio 4.08x 4.50x 5.09x 5.87x 6.85x 10.54x 8.98x 10.51x
Quick Ratio 3.69x 4.21x 4.88x 5.62x 6.64x 10.28x 8.78x 10.29x
Debt to Equity 6.12x 2.54x 1.60x 1.11x 0.30x 0.22x 0.00x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001885522) · from March 31, 2022 Data through September 30, 2026 · synced Nov 20, 2026, 05:50 UTC · Open in terminal